Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "liver"

3066 News Found

IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach
Healthcare | April 27, 2026

IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach

The deal signals a clear push to expand access to care in underserved regions


Vision 360 brings academia, industry together to advance ophthalmic therapies
Healthcare | April 25, 2026

Vision 360 brings academia, industry together to advance ophthalmic therapies

VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care


India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh
Policy | April 25, 2026

India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh

At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones


ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre
Hospitals | April 25, 2026

ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre

Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof


Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens
Supply Chain | April 25, 2026

Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens

Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1
News | April 25, 2026

Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1

The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network


Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade,  Head Bioprocessing, India, Avantor
interviews | April 24, 2026

Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Head Bioprocessing, India, Avantor

Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region


Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
Clinical Trials | April 24, 2026

Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens

The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c


New genomics clinic by Fortis Hospitals targets early disease detection
Healthcare | April 24, 2026

New genomics clinic by Fortis Hospitals targets early disease detection

New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care